Pharmaceuticals News

doctor-patientNov 20, 2014
England could lose 16,000 GPs

England could lose 16,000 GPs.

Read More
coffee-beansAug 28, 2014
FDA Approves Conversion of Soliris® (eculizumab) Accelerated Approval in aHUS to Regular Approval for the Treatment of Patients with aHUS

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Pellentesque auctor aliquam lectus eget venenatis. Nam fermentum est quam, sit amet […]

Read More
600x340_2Aug 28, 2014
European Medicines Agency Accepts Marketing Authorization Application for Asfotase Alfa as a Treatment for Patients with Hypophosphatasia

European Medicines Agency Accepts Marketing Authorization Application for Asfotase Alfa as a Treatment for Patients with HypophosphatasiaEuropean Medicines Agency Accepts […]

Read More
600x340_1Aug 28, 2014
European Commission Grants Orphan Drug Designation to Soliris® (eculizumab) for the Treatment of Patients with Myasthenia Gravis (MG)

European Commission Grants Orphan Drug Designation to Soliris® (eculizumab) for the Treatment of Patients with Myasthenia Gravis (MG)European Commission Grants […]

Read More